These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 36442440)

  • 1. Relationship of negative emotionality, NIAAA recovery, and 3- and 6-month drinking outcomes among adults in treatment for alcohol use disorder.
    Linn BK; Zhao J; Stasiewicz PR; LaBarre C; Wilding GE; Bradizza CM
    Drug Alcohol Depend; 2023 Jan; 242():109695. PubMed ID: 36442440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Addictions Neuroclinical Assessment Negative Emotionality Domain Among Treatment-Seekers with Alcohol Use Disorder: Construct Validity and Measurement Invariance.
    Votaw VR; Pearson MR; Stein E; Witkiewitz K
    Alcohol Clin Exp Res; 2020 Mar; 44(3):679-688. PubMed ID: 31957027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining Recovery From Alcohol Use Disorder: Development of an NIAAA Research Definition.
    Hagman BT; Falk D; Litten R; Koob GF
    Am J Psychiatry; 2022 Nov; 179(11):807-813. PubMed ID: 35410494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Longitudinal Mediation Model of Negative Emotionality, Coping Motives and Drinking Intensity Among Individuals Receiving Community Treatment for Alcohol Use Disorder.
    Votaw VR; Stein ER; Witkiewitz K
    Alcohol Alcohol; 2021 Aug; 56(5):573-580. PubMed ID: 33778864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of the screening suggested by the National Institute on Alcohol Abuse and Alcoholism and of a newly derived tool for the detection of unhealthy alcohol drinkers among surgical patients.
    Agabio R; Gessa GL; Montisci A; Finco G; Contu P; Bedogni G; Marchi A
    J Stud Alcohol Drugs; 2012 Jan; 73(1):126-33. PubMed ID: 22152670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying adolescents with alcohol use disorder: Optimal screening using the National Institute on Alcohol Abuse and Alcoholism screening guide.
    Parast L; Meredith LS; Stein BD; Shadel WG; D'Amico EJ
    Psychol Addict Behav; 2018 Aug; 32(5):508-516. PubMed ID: 29975071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examining the validity of the addictions neuroclinical assessment domains in a crowdsourced sample of adults with current alcohol use.
    Votaw VR; Boness CL; Stein ER; Watts AL; Sher KJ; Witkiewitz K
    Exp Clin Psychopharmacol; 2024 Feb; 32(1):68-83. PubMed ID: 37227882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between the WHO and NIAAA criteria for binge drinking on drinking features and alcohol-related aftermaths: Results from a cross-sectional study among eight emergency wards in France.
    Rolland B; Chazeron I; Carpentier F; Moustafa F; Viallon A; Jacob X; Lesage P; Ragonnet D; Genty A; Geneste J; Poulet E; Dematteis M; Llorca PM; Naassila M; Brousse G
    Drug Alcohol Depend; 2017 Jun; 175():92-98. PubMed ID: 28411560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validity and measurement invariance of the Addictions Neuroclinical Assessment incentive salience domain among treatment-seekers with alcohol use disorder.
    Stein ER; Votaw VR; Swan JE; Witkiewitz K
    J Subst Abuse Treat; 2021 Mar; 122():108227. PubMed ID: 33509416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Addictions Neuroclinical Assessment (ANA) framework through deep phenotyping of problem drinkers.
    Nieto SJ; Grodin EN; Green R; Ray LA
    Drug Alcohol Depend; 2021 Apr; 221():108603. PubMed ID: 33618192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors underlying the neurofunctional domains of the Addictions Neuroclinical Assessment assessed by a standardized neurocognitive battery.
    Gunawan T; Luk JW; Schwandt ML; Kwako LE; Vinson T; Horneffer Y; George DT; Koob GF; Ramchandani VA; Diazgranados N; Goldman D
    Transl Psychiatry; 2024 Jul; 14(1):271. PubMed ID: 38956031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and Correlates of Past-Year Recovery From DSM-5 Alcohol Use Disorder: Results From National Epidemiologic Survey on Alcohol and Related Conditions-III.
    Fan AZ; Chou SP; Zhang H; Jung J; Grant BF
    Alcohol Clin Exp Res; 2019 Nov; 43(11):2406-2420. PubMed ID: 31580502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compounding Vulnerability in the Neurocircuitry of Addiction: Longitudinal Functional Connectivity Changes in Alcohol Use Disorder.
    Fede SJ; Kisner MA; Manuweera T; Kerich M; Momenan R
    Alcohol Alcohol; 2022 Nov; 57(6):712-721. PubMed ID: 35760068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Equivalence of Alcohol Use Disorder Symptom Assessments in Routine Clinical Care When Completed Remotely via Online Patient Portals Versus In Clinic via Paper Questionnaires: Psychometric Evaluation.
    Matson TE; Lee AK; Oliver M; Bradley KA; Hallgren KA
    J Med Internet Res; 2024 Jul; 26():e52101. PubMed ID: 39038284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AUD Risk, Diagnoses, and Course in a Prospective Study Across Two Generations: Implications for Prevention.
    Schuckit MA
    Alcohol Res; 2022; 42(1):01. PubMed ID: 35036241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heavy Alcohol Use and Age Effects on HIV-Associated Neurocognitive Function.
    Cohen RA; Gullett JM; Porges EC; Woods AJ; Lamb DG; Bryant VE; McAdams M; Tashima K; Cook R; Bryant K; Monnig M; Kahler CW; Monti PM
    Alcohol Clin Exp Res; 2019 Jan; 43(1):147-157. PubMed ID: 30371953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Constructs derived from the addiction cycle predict alcohol use disorder treatment outcomes and recovery 3 years following treatment.
    Witkiewitz K; Stein ER; Votaw VR; Hallgren KA; Gibson BC; Boness CL; Pearson MR; Maisto SA
    Psychol Addict Behav; 2023 May; 37(3):376-389. PubMed ID: 35951419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neural correlates of the addictions neuroclinical assessment (ANA) incentive salience factor among individuals with alcohol use disorder.
    Nieto SJ; Grodin EN; Ray LA
    Behav Brain Res; 2024 Apr; 464():114926. PubMed ID: 38431152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methodology and Demographics of a Brief Adolescent Alcohol Screen Validation Study.
    Bromberg JR; Spirito A; Chun T; Mello MJ; Casper TC; Ahmad F; Bajaj L; Brown KM; Chernick LS; Cohen DM; Fein J; Horeczko T; Levas MN; McAninch B; Monuteaux M; Mull CC; Grupp-Phelan J; Powell EC; Rogers A; Shenoi RP; Suffoletto B; Vance C; Linakis JG;
    Pediatr Emerg Care; 2019 Nov; 35(11):737-744. PubMed ID: 29112110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reliability and Validity of a Two-Question Alcohol Screen in the Pediatric Emergency Department.
    Spirito A; Bromberg JR; Casper TC; Chun TH; Mello MJ; Dean JM; Linakis JG;
    Pediatrics; 2016 Dec; 138(6):. PubMed ID: 27940674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.